Geriatric assessment for older frail adults with blood cancer
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether a special check-up (called a geriatric assessment) can improve quality of life for older adults with blood cancer who are also frail. The goal is to help you feel better and manage treatments more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older
- You have a blood cancer (like leukemia, lymphoma, myeloma, or related conditions) that is either new, has come back, or is getting worse
- You are about to start or have just started (within the last 6 weeks) systemic cancer treatment (e.g., chemotherapy, pills, or shots)
- You are not strongly healthy—you have some frailty (a score of 14 or less on a special frailty test)
- You are expected to live more than 6 months, and you are not currently in the hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a comprehensive geriatric assessment (CGA) can help improve health planning for older adults. You may take part if you are an older patient at the Dalhousie Family Medicine Clinic.
This study tests a short screening questionnaire called G8 to see how well it helps doctors assess the health and needs of older adults (70+) with solid tumors before starting cancer treatment. If you join, you'll answer some simple questions about your daily life and overall health.
This trial tests whether remote health assessments and support can improve care for adults 65+ who are starting a new cancer treatment. You'd participate from home via telehealth visits.
This trial enrolls people age 70 or older who have been diagnosed with cancer and are being referred to a geriatrician for a health and care needs review. It tests whether this geriatric assessment and related care approach is useful for elderly cancer patients.
This study is developing a simple screening tool to help doctors better understand the overall health and needs of older cancer patients (65+). It aims to make sure elderly patients get the right support during cancer treatment.
This study looks at whether geriatric (age-related health) evaluations help doctors choose better treatment for newly diagnosed AML (a type of leukemia). It may help translate older adults’ needs into a clearer, safer treatment plan.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.